Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recurrence × 5-aminolevulinic acid hexyl ester × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 7 Recurrence 1 Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Dexamethasone 23 Rituximab 15 Gemcitabine 11 Cisplatin 11 pomalidomide 10 Paclitaxel 10 Lenalidomide 9 Bortezomib 9 Carboplatin 8 Cyclophosphamide 7 carfilzomib 6 Drug Therapy 5 Cytarabine 5 selinexor 4 ibrutinib 4 daratumumab 4 Temozolomide 4 Doxorubicin 4 Docetaxel 4 Bevacizumab 4 Aspirin 4 tisagenlecleucel 3 Vincristine 3 Prednisone 3 Cetuximab 3 Calcium Dobesilate 3 ofatumumab 2 galiximab 2 eculizumab 2 durvalumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02660190 2019-08-14

DaBlaCa-11

Aarhus University Hospital

Phase 3 Completed

Urinary Bladder Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡